MEDI — Medistim ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK4.17bn
- NOK4.01bn
- NOK699.77m
Annual cashflow statement for Medistim ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 90.9 | 114 | 135 | 134 | 207 |
| Depreciation | |||||
| Non-Cash Items | -13.3 | -19.2 | -25.7 | -27.3 | -25.1 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 27.1 | -4.6 | -20 | 11.7 | -10.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 128 | 113 | 113 | 143 | 187 |
| Capital Expenditures | -11.5 | -21.1 | -29.7 | -24.7 | -33 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -11.5 | -21.1 | -29.7 | -24.7 | -33 |
| Financing Cash Flow Items | 7.59 | 5.4 | 6.01 | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -59.1 | -70.3 | -84.9 | -91.5 | -123 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 57.6 | 23.2 | 1.23 | 25.3 | 32.9 |